Visual comparison of U.S. and EU patent equivalence tests

The Doctrine of Equivalents in European vs. U.S. Patent Law: Where Does Infringement Begin?

Introduction

Patent claims are the foundation of intellectual property protection, defining the boundary between protected innovation and the public domain. However, in practice, this boundary is not always clear. The doctrine of equivalents addresses situations like what happens if someone makes a minor change to a patented invention—yet achieves the same result in the same way? Is that still infringement?

Enter the doctrine of equivalents, a legal principle that prevents patents from being bypassed by superficial modifications. While both Europe and the United States recognize this doctrine, their application differs dramatically, often leading to divergent outcomes in nearly identical cases.

This article explores how the doctrine functions in each system and what inventors, businesses, and legal professionals need to understand to navigate both.


What Is the Doctrine of Equivalents?

In simple terms, the doctrine of equivalents allows courts to find infringement when an invention does not literally match the patent claims, but still performs substantially the same function, in substantially the same way, to achieve substantially the same result.

Key Principle:

If a variant of a patented invention performs substantially the same function, in substantially the same way, to achieve substantially the same result, it may be deemed equivalent and therefore infringing.


The U.S. Approach to the Doctrine of Equivalents

The U.S. has a well-developed and flexible doctrine of equivalents, largely shaped by case law, especially the landmark Supreme Court The United States uses a flexible, case-law-driven version of the doctrine. A key case is Graver Tank & Mfg. Co. v. Linde Air Products Co. (1950), in which the U.S. Supreme Court ruled that minor differences do not prevent a finding of infringement when the underlying substance is the same.

🔑 Key Features:

  • Function-Way-Result Test: Does the accused product do the same thing, in the same way, with the same result?
  • Prosecution History Estoppel: If a patent claim was narrowed during examination, the inventor might be barred from reclaiming that ground through equivalence.
  • Judicial Discretion: Application is up to the court, creating greater uncertainty.

đź§Ş U.S. Example:

A patent claims a printer with a copper heating element. A competitor uses aluminum, achieving the same heating effect. Under U.S. law, this may still infringe under the doctrine of equivalents.

Inventive Alliance

The European View: Structured but Narrow

In Europe, the doctrine is shaped by Article 69 of the EPC, its Protocol, and national court interpretations—particularly Actavis v. Eli Lilly (UK Supreme Court, 2017), which harmonized UK law with broader European standards.

🔑 Key Features:

  • Focus on legal certainty for third parties versus fair protection for inventors
  • 3-Step Test:
    1. Does the variant achieve substantially the same result in the same way?
    2. Would this have been obvious to a skilled person?
    3. Would a skilled person interpret the claim to exclude it?

While the doctrine exists, European courts often limit its reach, prioritizing clarity and predictability.

đź§Ş European Example:

In Actavis v. Eli Lilly, the UK Supreme Court ruled that a different salt form of a drug than listed in the patent could still infringe. This marked a shift from strict literal interpretation toward broader protection.


Key Differences Summarized

AspectU.S.Europe
Governing LawCase Law (e.g., Graver Tank)Article 69 EPC + Protocol
TestFunction-Way-Result3-Step Actavis Test
FlexibilityHighModerate to Low
EmphasisPatentee’s rightsLegal certainty for third parties
EstoppelStrong (limits equivalence)Generally weaker or not applied

Why These Differences Matter

For inventors and global businesses, understanding these contrasts is critical:

  • A product may avoid literal infringement in one jurisdiction but still infringe under equivalents in another.
  • Claim drafting becomes a strategic tool: language must be both precise and flexible.
  • Litigation risk and enforcement potential hinge on how each system applies the doctrine.

To dive deeper into litigation avoidance, see Patent Infringement Loopholes: How Companies Skirt Liability Legally.


Conclusion: Two Doctrines, One Objective

While Europe’s and America’s approaches differ, both strive to protect inventors from copycats who exploit claim wording. Recent case law shows Europe is slowly converging toward broader protection, but national differences persist.

Ultimately, understanding the doctrine of equivalents in both systems is essential to maximizing protection and minimizing enforcement gaps. Whether you’re drafting claims or launching products, the doctrine defines how close is too close—legally speaking.

For further tips on drafting winning claims, read The Art of Patent Drafting: Crafting Claims That Win in Court.


Further Reading & References

  1. Graver Tank & Mfg. Co. v. Linde Air Products Co., 339 U.S. 605 (1950)
  2. Actavis UK Ltd v Eli Lilly and Co [2017] UKSC 48
  3. European Patent Office: Guidelines for Examination – Article 69 EPC
  4. Patents for Inventors by Craig Allen Nard – Chapters on claim interpretation and equivalents
  5. WIPO Lex Database – International legal standards and treaties on patent law

Leave a Reply

Discover more from Inventive Alliance

Subscribe now to keep reading and get access to the full archive.

Continue reading